INVESTIGATION OF DRUG UTILIZATION STATUS AND SAFE DRUG UTILIZATION INFORMATION IN PREGNANT WOMEN

Year 2020, Volume: 23 Issue: 4, 463 - 469, 25.12.2020

Asuman Çobanoğlu

https://doi.org/10.17049/ataunihem.499684

Cited By: 2

Abstract

Aim: This study was carried out to investigate the drug utilization status of pregnant women and the drug utilization and drug safety information during pregnancy.
Methods: The sample of the cross-sectional and descriptive study consisted of 378 pregnant women who were calculated as a result of power analysis and who met the research criteria. The data were collected with a 19-item questionnaire which was created by the researcher by literature review. Data analysis was performed using SPSS 15.0 package program. In order to conduct the research, both the approval of the institution and the ethics committee were obtained.
Results: It was determined that the average age of the pregnant women in the research sample was 28.43±5.47 years, 52.4% of them were living in the district and 42.9% of them had secondary education. It was found that 90.2% of the pregnant women was on medication during pregnancy and 77.8% of them took vitamins/mineral drugs and 4% of them used drugs other than the doctor's recommendation. It was determined that 75.4% of the pregnant women received information about the drug utilization, 44.4% of them informed by the physician, 16.7% of them informed by the midwife/nurse and 12.7% of them received information from the internet.
Conclusion: In the study, it was found that the rate of drug utilization during pregnancy was very high (90.2%), and most pregnant women use vitamins and minerals drugs (96.4% doctor’s recommendation), the information about the drug utilization was reached commonly from the physician in pregnancy, and as internet source, they used the websites which are not safe and does not contain scientific data.

Keywords

Rational drug use, Pregnancy, Medication

GEBELERİN İLAÇ KULLANIM DURUMU VE GÜVENLİ İLAÇ KULLANIMI BİLGİLERİNİN İNCELENMESİ

Abstract

Amaç: Çalışma gebelerin ilaç kullanımı ile gebelikte ilaç kullanım durumları ve ilaç güvenliği bilgilerinin incelenmesi amacıyla yapıldı.
Yöntem: Kesitsel ve tanımlayıcı tipteki çalışmanın örneklemini güç analizi sonucunda hesaplanan ve araştırma kriterlerine uyan 378 gebe kadın oluşturdu. Araştırma verileri araştırmacı tarafından literatür taranarak oluşturulan 19 sorudan oluşan bir form ile toplandı. Verilerin analizi SPSS 15.0 paket programı kullanılarak gerçekleştirildi. Araştırmanın yapılabilmesi için hem kurum izni hem de etik kurul izni alındı.
Bulgular: Araştırma örneklemindeki gebe kadınların yaş ortalamasının 28.43±5.47 yıl olduğu, %52.4'ünün ilçede yaşadığı, %42.9'unun ortaöğrenim gördüğü saptandı. Gebe kadınların %90.2'sinin gebelikte ilaç kullandığı ve %77.8'inin vitamin/mineral ilaçları aldığı, %4'ünün ise hekim önerisi dışında ilaç kullandığı saptandı. Gebelerin %75.4'ünün ilaç kullanımı ile ilgili bilgi aldığı, bilgi alanların %44.4'ünün hekim tarafından, %16.7'sinin ebe/hemşire tarafından bilgilendirildiği ve %12.7'sinin internetten bilgi edindiği belirlendi.
Sonuç: Çalışmada gebelerin gebelik sürecinde ilaç kullanım oranının oldukça yüksek olduğu (%90.2) en çok besin takviyesi olan vitamin ve mineral içeren ilaçları kullandıkları (%96.4’ünün hekim önerisi ile), gebelikte ilaç kullanımı ile bilgileri en sık hekimden aldıkları, internet kaynağı olarak güvenli ve bilimsel verileri içermeyen internet sitelerini kullandıkları saptandı.

Keywords

akılcı ilaç kullanımı, Gebelik, ilaç

References

• 1. Sinclair M, Lagan BM, Dolk H, McCullough J. An assesment of pregnant women’s knowledge and use of the internet for medication safety information and purchase. Journal of Advanced Nursing 2018;74(1):137-47.
• 2. Demirkan K. Gebelikte ilaç kullanımı. TEB Adana Eczacı Odası Dergisi 2006; 13:32-3.
• 3. Petersen I, McCrea RL, Lupattelli A, Nordeng H. Womens perception of risks of adverse fetal pregnancy outcomes. BMJ Open 2015;5:1-9.
• 4. Olukman M, Parlar A, Orhan CE, Erol A. Gebelerde ilaç kullanımı: Son bir yıllık deneyim. Turkish Journal of Obstetrics and Gynecology 2006;3(4):255-61.
• 5. Riley LE, Cahill AG, Beigi R, Savich R, Scade G. Improving safe and effective use of drugs in pregnancy and lactation. American Journal of Perinatology 2017;34(8):826-32.
• 6. Oliveire-Filho A, Veire AES, Silvo RC, Neves STF, Gama TAB, Lima RV, Oliveire WR, Dias JM. Adverse drug reactions in high risk pregnant women. Saudi Pharmaceutical Journal 2017;25(7):1073-7.
• 7. Aljoher AM, Alsaced MA, Allchlfan MA, Almethen AW. Almukhaitah MA, Zareen H. et al. Pregnant women risk perception of medications and natural products use during pregnancy in Alahsa, Saudi Arabia. The Egyptian Journal of Hospital Medicine 2018;70(1):13-20.
• 8. Daw JR, Hanley GE, Greyson DL, Morgan SG. Prescription drug use during pregnancy in developed countries. Pharmacoepidemiol Drug Safety 2011;20(9):895-902.
• 9. Mitchell AA, Gilboa SM, Werler MM, Kelley KE, Louik C, Hernández-Díaz S. Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. American Journal of Obstetrics & Gynecology 2011;205:51.e1-8.
• 10. Lupattelli A, Spigset O, Twigg MJ, Zagorodnikova K, Mårdby AC, Moretti ME. Et al. Medication use in pregnancy: a Cross-sectional, multinational web-based study. BMJ Open 2014; 4(2):e004365.
• 11. Kaplan YC, Can H, Demir Ö, Karadaş B, Yılmaz İ, Temiz TK. İlaçların gebelikte kullanımlarına dair risk iletişiminde yeni dönem. Türk Aile Hekimliği Dergisi 2014;18(4):195-8.
• 12. Petersen I, McCrea RL, Lupattelli A, Nordeng H. Women’s perception of risks of adverse fetal pregnancy outcomes. BMJ Open 2015;5:e007390.
• 13. Öztürk Z. Gebelikte ilaç kullanımı ve risk değerlendirmesi: Beni kategorize etme. Zeynep Kamil Tıp Bülteni 2018;49(1):109-12.
• 14. Hegaard HK. The effect of a multimodal interdisciplinary maternity care intervention on lenght of hospitalization. CMAJ 2018. ClinicalTrials.gov NCT03511508
• 15. Jolving LR, Nielsen J, Kesmodel US, Nielsen RG, Beck-Nielsen SS, Norgard BM. Prevalence of maternal chronic diseases during pregnanacy. Acta Obstetricia et Gynecologica Scandinavica 2016; 95(11):1295-304.
• 16. Şahin M, Yurdakul M. Preconceptional care. Florance Nightingale Journal of Nursing 2012;20(1):80-5.
• 17. Koç Z, Sağlam Z, Topatan S. Determination of the usage of complementary and alternative medicine among pregnant women in the northern region of Turkey. Collegian 2017;24(6):533-9.
• 18. Onyiapat JI, Okafor C, Okoronkwo I, Anarado A, Chukwukelu E, Nwaneri A. et al. Complementary and alternative medicine use: Results from a descriptive study of pregnant women in Udi Local Government Area of Enugu State, Nigeria. BMC Complementary and Alternative Medicine 2017;17:189.
• 19. Shakuat A, Gnanasan S, Farooqui M. Women’s perspectives towards traditional and complementary medicine used to conceive, during pregnancy and the postpartum period. Complementary Therapies in Clinical Practice 2018; 30:109-15.
• 20. Yusof J, Mahdy ZA, Noor RM. Use of complementary and alternative medicine in pregnancy and its impact on obstetric outcome. Complementary Therapies in Clinical Practice 2016;25:155-63.
• 21. Pallivalappila AR, Stewart D, Shetty A, Pande B, Singh R, McLay JS. Use of complementary and alternative medicines during the third trimester. Obstetrics Gynecology 2015;125(1):204-11.
• 22. Hwang JH, Kim YR, Ahmed M, Choi S, Al-Hammadi NQ, Widad NM. et al. Use of complementary and alternative medicine in pregnancy: Across-Sectional Survey on Iraqi Women. BMC Complementary and Alternative Medicine 2016;16:191.
• 23. Ramirez-Velez R, Bautista JEC, Reina HRT, Jimenez EG, Riovalle JS, Ruiz KG. Use of dietary supplements by pregnant women in Colombia. BMC Pregnancy and Childbirth 2018; 18:117.
• 24. Molla F, Assen A, Abrha S, Masresha B, Gashaw A, Wondimu A. et al. Prescription drug use during pregnancy in Southern Tigray Region, North Ethiopia. BMC Pregnancy and Childbirth 2017; 17:170.
• 25. Akça A, Sürücü GŞ, Akbaş M. Gebelerde sağlık algısı, sağlık okuryazarlığı ve ilişkili faktörler. İnönü Üniversitesi Sağlık Hizmetleri Meslek Yüksekokulu Dergisi 2020;8(3):630-42.
• 26. Anttila KH, Kokki E, Lupattelli A, Nordeng H, Jyrkkä J, Vainio K. et al. Factors associated with the need for information about medicines among pregnant women. Research in Social and Administrative Pharmacy 2015;11(2):297-302.
• 27. Larsson M. A Descriptive Study of the use of the internet by women seeking pregnancy-related information. Midwifery 2009;25(1):14-20.
• 28. Twigg MJ, Lupattelli A, Nordeng, H. Women’s beliefs about medication use during their pregnancy: A UK Perspective. International Journal of Clinical Pharmacy 2016;38(4):968-76.